Bayview Legacy LLC sells 70,000 Arteris shares

Bayview Legacy, LLC, a ten percent owner of Arteris, Inc., reported an open-market sale of 70,000 shares of Arteris common stock.

Rhea-AI Filing Summary

Bayview Legacy, LLC, a ten percent owner of Arteris, Inc., reported an open-market sale of 70,000 shares of Arteris common stock. The sale occurred on April 8, 2026 at a weighted average price of $19.0398 per share, with individual trade prices ranging from $18.67 to $19.43.

The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025 by K. Charles Janac, the manager of Bayview Legacy, LLC. Following the sale, Bayview Legacy, LLC indirectly held 9,119,071 shares of Arteris common stock, over which Janac is deemed to have voting and dispositive power.

Insider Trade Summary 10b5-1

Net Seller: 70,000 shares

Net Sell 1 txn

Insider Bayview Legacy, LLC

Role 10% Owner

Sold 70,000 shs ($1.33M)

Type	Security	Shares	Price	Value
Sale	Common Stock	70,000	$19.0398	$1.33M

Holdings After Transaction: Common Stock — 9,119,071 shares (Indirect, See Footnote)

Footnotes (4)

1. F1. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
2. F2. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.
3. F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.43 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Key Figures

Shares sold: 70,000 shares Weighted average sale price: $19.0398 per share Sale price range: $18.67–$19.43 +2 more

5 metrics

Shares sold 70,000 shares Open-market sale on April 8, 2026

Weighted average sale price $19.0398 per share Average price for 70,000 shares sold

Sale price range $18.67–$19.43 Range of individual trade prices in the sale

Shares held after transaction 9,119,071 shares Indirect holdings of Bayview Legacy, LLC after sale

10b5-1 plan adoption date March 5, 2025 Date K. Charles Janac adopted trading plan

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, beneficial ownership, voting and dispositive power

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

beneficial ownership financial

"given his beneficial ownership of the reported security through Bayview Legacy, LLC"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

voting and dispositive power regulatory

"is deemed to have voting and dispositive power over the shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bayview Legacy, LLC report for Arteris (AIP)?

Bayview Legacy, LLC reported selling 70,000 shares of Arteris common stock. The open-market sale occurred on April 8, 2026 at a weighted average price of $19.0398 per share under an established trading plan.

At what prices were the Arteris (AIP) shares sold in this Form 4?

The shares were sold at a weighted average price of $19.0398 per share. Individual transactions occurred at prices ranging from $18.67 to $19.43, as disclosed in the weighted-average pricing footnote.

How many Arteris (AIP) shares does Bayview Legacy, LLC hold after the reported sale?

After the transaction, Bayview Legacy, LLC indirectly held 9,119,071 shares of Arteris common stock. K. Charles Janac, as manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares.

Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?

Yes. The transaction was made pursuant to a Rule 10b5-1 trading plan. The plan was adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on March 5, 2025, indicating the sale was pre-arranged.

Who is associated with Bayview Legacy, LLC in this Arteris (AIP) Form 4 filing?

K. Charles Janac is identified as the manager of Bayview Legacy, LLC. He is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC and separately filed his own Form 4 for the same transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/09/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/08/2026		S(1)(2)		70,000	D	$19.0398(3)	9,119,071	I	See Footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

2. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.43 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Remarks:

	/s/ K. Charles Janac	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)